14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Hold
Today BLCM ranks #14447 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Bellicum Pharmaceuticals Stock Forecast NASDAQ:BLCM

$1.72 (4.88%)

Volume: 94k

Closed: Dec 08, 2021

Hollow Logo Score: -1.667

Bellicum Pharmaceuticals Stock Forecast

$1.72 (4.88%)

Volume: 94k

Closed: Dec 08, 2021

Score Hollow Logo -1.667
Which way will BLCM go? Request
Key Stats
Beta 1.28
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 32 and the stock is currently not being overbought or oversold

Green day on Wednesday for Bellicum Pharmaceuticals
(Updated on Dec 08, 2021)

Sell candidate since 2021-10-06 Loss -38.13%

The Bellicum Pharmaceuticals stock price gained 4.88% on the last trading day (Wednesday, 8th Dec 2021), rising from $1.64 to $1.72. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 10.00% from a day low at $1.60 to a day high of $1.76. The price has fallen in 5 of the last 10 days, but is still up by 0.58% over the past 2 weeks. Volume fell on the last day by -13 thousand shares and in total, 94 thousand shares were bought and sold for approximately $162.44 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.76 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -47.04% during the next 3 months and, with a 90% probability hold a price between $0.82 and $0.93 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are mixed signals in the stock today. The Bellicum Pharmaceuticals stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.95. On a fall, the stock will find some support from the short-term average at $1.70. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Monday, December 06, 2021, and so far it has risen 7.50%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss

Bellicum Pharmaceuticals finds support from accumulated volume at $1.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.16 between high and low, or 10.00%. For the last week the stock has had a daily average volatility of 10.59%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Bellicum Pharmaceuticals stock A Buy?

Bellicum Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.667

Predicted Opening Price for Bellicum Pharmaceuticals of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$1.69 $1.72 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

Wells Fargo & Company does not see either upside or downside right now giving BLCM "Overweight - Equal Weight" on their last update on Oct 30, 2020. The price target was set to $4.50.

Volatility and Risk
Daily Average Volatility: 10.59 %
Overall Risk: Very High High Medium Low Very Low
10.59 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $1.87
Price: $1.72
Support: $1.71

BLCM Insider Trading Show all Trades



Last 100 transactions
Buy: 5 665 216 | Sell: 34 512 (Shares)
Date Action Amount Person Type
Dec 01, 2021 Buy 150 000 Scripture Charity Stock Option (right to buy)
Aug 16, 2021 Buy 265 000 Fair Richard A. Stock Option (right to buy)
Jul 01, 2021 Buy 809 Daly James M Restricted Stock Units
Jul 01, 2021 Buy 566 Klimovsky Judith V Restricted Stock Units
Jun 15, 2021 Buy 6 500 Huber Reid M Stock Option (right to buy)
Show all Insider Trades


Last 100 transactions
Buy: 5 665 216 | Sell: 34 512 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.85 7.75 %
1.79 4.20 %
1.75 2.00 %
Current price: 1.72
Support 1.63 -5.10 %
1.59 -7.30 %
1.53 -10.85 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 2.05 19.19 %
2.04 18.60 %
1.87 8.72 %
Current price 1.72
Support 1.71 -0.58%
1.64 -4.65%
1.60 -6.98%

Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers, solid tumors, and orphan inherited blood disorders in the United States and internationally. Its clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials, administered after allogeneic hematopoietic stem cell trans... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE